Anualidad

Anualidad RDF

páginas:

To what extent does past performance influence network formation in clusters? Evidence from the Valencia region Conference Paper 2013 Congress communication
To what extent is gout a curable disease?. Curso Teórico-Práctico de Análisis de Líquido sinovial. Sociedad Italiana de Reumatología Invited Talk 2002 Invited conference
TOA cabestrillo de tensión regulable Invited Talk 2011 Invited conference
Tobacco as a source of microplastics and respiratory health Academic Article 2022
Tobacco is a Leading Risk Factor for Liver and Extrahepatic Cancers in Patients With Liver Cirrhosis: A Prospective Cohort Study Academic Article 2024
Tobacco smoking and gastric cancer: meta-analyses of published data versus pooled analyses of individual participant data (StoP Project) Academic Article 2018
Tobacco smoking and gastric cancer: meta-analyses of published data versus pooled analyses of individual participant data (StoP Project). Academic Article 2017
Tobillo o articulación talocrural. Articulación troclear formada por el astrágalo y la región distal de la tibia y el peroné (1ª parte) Academic Article 2001
TOCILIZUMAB EN 22 PACIENTES CON ARTERITIS DE CE¿LULAS GIGANTES Conference Poster 2015 Congress communication
TOCILIZUMAB EN ARTERITIS DE CÉLULAS GIGANTES DE RECIENTE DIAGNÓSTICO VERSUS REFRACTARIA/RECURRENTE. ESTUDIO MULTICÉNTRICO DE 471 PACIENTES DE LA PRÁCTICA CLÍNICA Conference Poster 2022 Congress communication
TOCILIZUMAB EN ARTERITIS DE TAKAYASU EN CAUCÁSICOS: ESTUDIO MULTICÉNTRICO DE 54 PACIENTES Conference Poster 2021 Congress communication
TOCILIZUMAB EN ARTERITIS DE TAKAYASU. ESTUDIO NACIONAL MULTICÉNTRICO DE 53 PACIENTES EN PRÁCTICA CLÍNICA Conference Paper 2020 Congress communication
TOCILIZUMAB EN LA AFECTACIÓN VISUAL DE LA ARTERITIS DE CÉLULAS GIGANTES. ESTUDIO MULTICÉNTRICO DE 471 PACIENTES DE PRÁCTICA CLÍNICA Conference Poster 2021 Congress communication
TOCILIZUMAB EN LA ARTERITIS DE CÉLULAS GIGANTES CON AFECTACIÓN DE VASO GRANDE Y EN LA ARTERITIS DE TAKAYASU. ESTUDIO OBSERVACIONAL MULTICÉNTRICO COMPARATIVO Conference Poster 2022 Congress communication
TOCILIZUMAB EN LA PRA¿CTICA CLI¿NICA EN 31 PACIENTES CON ARTERITIS DE CE¿LULAS GIGANTES. EVOLUCIO¿N A CORTO Y LARGO PLAZO Conference Poster 2017 Congress communication
TOCILIZUMAB EN LOS FENOTIPOS CRANEAL Y EXTRACRANEAL DE LA ARTERITIS DE CÉLULAS GIGANTES. ESTUDIO MULTICÉNTRICO DE 471 PACIENTES Conference Paper 2021 Congress communication
TOCILIZUMAB FOR TAKAYASU ARTERITIS: MULTICENTER STUDY OF 54 WHITE PATIENTS Conference Poster 2021 Congress communication
Tocilizumab in Caucasian Patients with Takayasu Arteritis: Multicenter Study of 54 Patients Conference Poster 2021 Congress communication
TOCILIZUMAB IN CRANIAL AND EXTRACRANIAL REFRACTORY GIANT CELL ARTERITIS: A MULTICENTER STUDY OF 312 CASES Conference Paper 2021 Congress communication
Tocilizumab in Giant Cell Arteritis. National Multicenter Study of 134 Patients of Clinical Practice Conference Poster 2018 Congress communication
Tocilizumab in giant cell arteritis. national multicenter study of 134 patients of clinical practice Conference Poster 2018 Congress communication
Tocilizumab in giant cell arteritis. Observational, open-label multicenter study of 134 patients in clinical practice Academic Article 2019
Tocilizumab in giant cell arteritis: differences between the GiACTA trial and a multicentre series of patients from the clinical practice. Academic Article 2020
Tocilizumab in giant cell arteritis: Multicenter open-label study of 22 patients Academic Article 2015
Tocilizumab in Giant Cell Arteritis: Route of Administration: Intravenous or Subcutaneous Conference Poster 2019 Congress communication
Tocilizumab in Giant Cell Arteritis: The Safest and Most Effective Initial Dose of Prednisone Conference Poster 2019 Congress communication
Tocilizumab in Giant Cell Arteritis:Multicenter Open-Label Study of 22 Patients. Conference Poster 2014 Congress communication
Tocilizumab in giant cell arteritis_ differences between the GIACTA trial and a multicentre series of patients from clinical practice Academic Article 2020
Tocilizumab in Large-Vessel Giant Cell Arteritis and Takayasu Arteritis: Multicentric Observational Comparative Study Conference Poster 2022 Congress communication
TOCILIZUMAB IN LARGE-VESSEL GIANT CELL ARTERITIS AND TAKAYASU ARTERITIS: MULTICENTRIC OBSERVATIONAL COMPARATIVE STUDY Conference Poster 2022 Congress communication

páginas: